Back
Guardant Health 10K Form
Sell
38
GH
Guardant Health
Last Price:
$31.67
Seasonality Move:
10%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GH News And Ratings
See the #1 stock for the next 7 days that we like better than GH
GH Financial Statistics
Sales & Book Value
| Annual Sales: | $563.9M |
|---|---|
| Cash Flow: | $-55.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.49 |
| Price / Book: | 28.68 |
Profitability
| EPS (TTM): | -4.24000 |
|---|---|
| Net Income (TTM): | $-512.4M |
| Gross Margin: | $336.9M |
| Return on Equity: | -651% |
| Return on Assets: | -30.37% |
Guardant Health Earnings Forecast
Key Guardant Health Financial Ratios
-
The Gross Profit Margin over the past 8 years for GH is 59.74%.
-
The Selling, General & Administrative Expenses for GH have been equal to 79.98% of Gross Profit Margin.
-
The Research & Development expenses have been 65.11% of Revenue.
-
The Interest Expense is -0.54% of Operating Income.
-
The Net Earning history of GH is -85.02% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 2 years.
Guardant Health Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | GH |
| CUSIP: | 40131M |
| Website: | guardanthealth.com |
Debt
| Debt-to-Equity Ratio: | -19 |
|---|---|
| Current Ratio: | 6.22 |
| Quick Ratio: | 5.51 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GH Technical Analysis vs Fundamental Analysis
Sell
38
Guardant Health (GH)
is a Sell
Is Guardant Health a Buy or a Sell?
-
Guardant Health stock is rated a SellThe current Guardant Health [GH] share price is $31.65. The Score for GH is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.